Magnesium L-threonate, sold mostly under the brand name Magtein, is the magnesium marketed for the brain. Labels call it the form that crosses the blood-brain barrier, studies are quoted as reversing "brain age" by about nine years, and it costs several times as much as ordinary magnesium. The idea came from a well-designed 2010 rat study at MIT, and the human research since then is real. But it is small, mostly funded by the companies that sell the ingredient, and less impressive than the marketing suggests.
Here is what the trials tested, in whom, who paid for them, and what it means for a bottle that costs about a dollar a day.
The short version
- The brain claim comes from rodents. In rats and mice, magnesium L-threonate raised magnesium in the brain or spinal fluid. We found no human study that has measured brain or spinal fluid magnesium after taking it.
- It is not the only magnesium that reaches the brain. Other forms raised brain magnesium in rat studies too, and in a 2026 rat comparison another form, magnesium acetyl taurate, did better.
- Human cognition results are limited and mostly sponsored. Two company-funded trials found gains on combined cognitive scores, large in a 44-person trial and small in a 100-person trial where placebo also improved; the one independent trial we found that measured cognition showed no significant difference.
- The "brain age" numbers are calculations, not measurements. The 9-year figure was derived after the fact from one test in 44 people, in a trial that, as the paper discloses, was funded, analyzed and written up by the ingredient's developer.
- Sleep results are mixed. Some wearable or questionnaire scores improved in single trials, but the main insomnia measures did not beat placebo.
- It is expensive magnesium. The usual 2 g dose gives about 144 mg of magnesium, at about $1 to $2.30 a day, several times the cost of magnesium glycinate.
- Memory problems need a medical check. New or worsening memory trouble, and conditions such as ADHD or dementia, belong with a clinician; this is not a treatment for any of them.
- Safety basics. Count it toward the 350 mg daily limit for supplemental magnesium, ask a clinician first if you have kidney disease or are pregnant or breastfeeding, and space it from bisphosphonates and some antibiotics.
What magnesium L-threonate is
Magnesium L-threonate is magnesium bound to L-threonic acid, a compound the body produces when it breaks down vitamin C. It was developed by neuroscientist Guosong Liu and colleagues, patented by Magceutics, whose patents are now held by Neurocentria, and sold as Magtein, an ingredient licensed to supplement brands. Another version of the same compound, tested in an early trial, was called MMFS-01.
Regulators treat it as a magnesium source, not a brain ingredient. In 2014, FDA responded with no questions to a notice that it is generally recognized as safe as a source of magnesium in foods. In 2024, the European Food Safety Authority concluded it is safe as a novel food at up to about 3,000 mg a day (about 250 mg of magnesium) and is a source from which magnesium is bioavailable, and the EU then authorized it for adult food supplements, excluding pregnant and breastfeeding women. Neither regulator evaluated brain benefits.
The evidence at a glance
| The claim | What was tested | Best evidence | Our read |
|---|---|---|---|
| It raises brain magnesium | Brain and spinal fluid magnesium in rats and mice | Raised in several rodent studies; we found no human measurement after taking it | Shown in rodents only |
| It is the only magnesium that crosses the blood-brain barrier | Rodent comparisons of magnesium forms | Acetyl taurate (rats and mice) and citrate (mice) also raised brain magnesium; acetyl taurate beat it in a 2026 rat comparison | Not supported |
| It improves thinking and memory | Placebo-controlled trials in adults | Gains on combined cognitive scores in two company-funded trials (44 and 100 people); no significant difference in the one independent trial we found that measured cognition (109 people) | Possible effect, not independently replicated |
| It reverses brain age by about 9 years | A calculation from one timed test | Derived after the fact in 44 people; not a registered or measured outcome | Not a valid measure of brain age |
| It improves sleep | Questionnaires and sleep-tracking rings | Insomnia score no significant difference (80 people); some ring and waking scores favored it; ring sleep scores no significant difference in a 100-person trial | Mixed, weak |
| It eases anxiety | Anxiety scores as secondary outcomes | No significant difference in the trials we found; none we found in people with an anxiety disorder | Not shown |
These summaries describe research. They are not claims about what a supplement does, and magnesium L-threonate is not a treatment for any condition. New or worsening memory problems need a medical evaluation. Supplemental magnesium should stay at or under 350 mg a day for adults unless a clinician advises otherwise; people with kidney disease, those taking prescription medicines, and pregnant or breastfeeding women should ask a clinician first.
The rodent studies behind the claim
The 2010 study. The idea began with a study in the journal Neuron from a team at MIT. In rats, magnesium L-threonate raised brain magnesium and improved learning, working memory, and short- and long-term memory, with more synaptic connections in memory regions of the brain. It was careful work, and it is the source of the "crosses the blood-brain barrier" claim. A later paper by the same group, citing it, reported that cerebrospinal fluid magnesium rose by about 15 percent. The effective rat dose was about 50 mg of magnesium per kilogram a day; by the standard body-surface conversion, our arithmetic puts that at roughly 560 mg of magnesium a day for a 70 kg adult, several times what human products supply.
Follow-up studies. Related work found the compound helped rats retain fear-extinction learning, and that it reduced amyloid plaque and prevented memory decline in a mouse model of Alzheimer's disease. An earlier version of that mouse study, published in 2013, was retracted by its authors in 2014; the same group published similar findings in another journal that year. In a Parkinson's disease study in mice, magnesium L-threonate raised cerebrospinal fluid magnesium in healthy mice while magnesium sulfate did not, and it reduced motor deficits in the disease model. Not every animal study was positive: in hypothyroid rats it reduced amyloid without improving cognition.
Other forms reach the brain too. All magnesium enters the brain through regulated transport, so the question is how much. Single-dose studies of other forms found brain magnesium rose with magnesium acetyl taurate in rats and mice, and with citrate in mice. In a 2026 rat study from one lab that compared acetyl taurate directly with magnesium L-threonate, at doses not stated as equal amounts of magnesium and with funding that PubMed lists from Celagenex Research, where two coauthors are listed as chief scientific officers, acetyl taurate raised tissue magnesium more and produced larger improvements in cognition and coordination.
What has not been measured. We found no human study that measured brain or cerebrospinal fluid magnesium after taking magnesium L-threonate; the trial investigators note that current technology cannot safely measure magnesium inside human neurons, and used blood cell magnesium instead. The one human brain-imaging study of a magnesium supplement we found used a different form, magnesium lactate, for a month in 30 men, and brain magnesium did not change.
Human trials on thinking and memory
- The 2016 trial (MMFS-01). 51 adults aged 50 to 70 with memory complaints, anxiety and sleep problems took 1.5 to 2 g a day or placebo for 12 weeks; 44 completed. A combined cognitive score improved more than placebo (P = 0.003), a large effect for a 44-person trial, with a wide margin of uncertainty. Individual tests were mixed: a timed task-switching test showed an overall treatment effect across the trial (P = 0.047) but did not differ significantly at week 6 or week 12, a memory span test improved at 6 weeks but not 12, and the face-name memory and attention tests did not differ significantly. The paper discloses that the developer funded the trial, analyzed the cognitive tests and wrote the paper. The ClinicalTrials.gov record shows it was first registered after the study was completed, with magnesium status, not cognition, as the primary outcome.
- The 2026 Magtein trial. 100 adults aged 18 to 45 who were dissatisfied with their sleep took 2 g of Magtein (145 mg of magnesium) or placebo for six weeks. This was the best-designed trial we found: registered in advance, with a pre-specified primary outcome. A total cognition score improved more with Magtein (P = 0.043), though both groups improved (8.4 points with Magtein and 5.6 with placebo), and reaction time, heart rate and heart rate variability also favored it. A reasoning test did not differ. Threotech, the company that produces Magtein, funded the study, supplied the product and helped design it.
- A combination product. A 2022 trial in 109 Chinese adults found a formula of magnesium L-threonate with phosphatidylserine and vitamins C, D and B6 improved memory test scores over 30 days. Because the formula had several active ingredients, it cannot show what magnesium L-threonate did on its own; the product was supplied by its developer.
- The independent trial. A 2023 government-funded, registered trial in 109 women after breast cancer surgery tested 1.2 g a day of a different maker's magnesium L-threonate for 12 weeks. There were no significant differences from placebo in pain, anxiety, depression, sleep quality or cognition. The dose (about 92 mg of magnesium) was lower than in other trials, pain was the main outcome, and cognition was a telephone screening test given only at follow-up, so it is a weak test of memory effects.
- ADHD. A 15-person open-label pilot in adults with ADHD reported improvement, with no placebo group. A larger company-run trial in 223 adults with ADHD tested a sustained-release product (NRCT-101SR) from the company behind magnesium L-threonate; the registry does not name its active ingredient. It posted results on ClinicalTrials.gov showing similar scores in both groups on both main measures, and no statistical analysis was posted. A university-led, company-supported trial in schizophrenia (60 people) also posted results close to placebo.
- Pain. Another independent trial, in 83 people with advanced cancer, found magnesium L-threonate slowed the rise in opioid doses, though anxiety and depression scores did not differ from placebo.
The fair summary: in small, mostly industry-funded trials, magnesium L-threonate produced improvements on combined cognitive scores, and the one independent trial we found that measured cognition showed no significant difference, though it was a weak test. A 2024 systematic review of magnesium and cognition included three double-blind trials with cognitive scores and judged them insufficient to draw conclusions. Its only magnesium L-threonate trial was the independent breast cancer trial, which it rated at high risk of bias and noted used a relatively low dose; it did not include the 2016 trial.
Where the "brain age" numbers come from
Many labels and articles say magnesium L-threonate reversed brain aging by about nine years. That figure comes from the 2016 trial, where the authors took the improvement on one timed test (a test that did not differ significantly from placebo at 12 weeks) and matched it to published norms for how that test's scores change with age. On that mapping, the treated group improved by the equivalent of 9.4 years and the placebo group by 0.8 years. It was calculated after the fact, from one test, in 44 people, in a trial whose registered primary outcome was magnesium status. It is not a measure of the brain's biological age.
The 2026 Magtein trial reported a similar "7.5-year reduction in cognitive age," also as an exploratory calculation from the cognitive score. These numbers describe test performance on a scale borrowed from age norms. They are not evidence that the brain became younger.
Sleep, anxiety and mood
Sleep. In a 2024 trial, 80 adults with sleep complaints took 1 g of Magtein or placebo for 21 days. The insomnia severity questionnaire, one of several primary measures, improved in both groups with no significant difference (P = 0.39), while a questionnaire on how people felt after waking favored Magtein, as did several sleep-tracking ring scores, including deep and REM sleep scores, and some mood and alertness ratings. A correction published later disclosed that the trial was registered retrospectively and that three authors had received compensation from the ingredient's distributor. In the 2026 Magtein trial, none of the ring-measured sleep outcomes differed from placebo, one of three sleep questionnaires improved, and the others did not, though sleep disturbance improved in the subgroup with the worst sleep. The 2016 trial and the independent 2023 trial also found no significant sleep effect. A 2026 trial of a nighttime blend containing magnesium L-threonate with L-theanine and apigenin found no improvement in sleep or stress after two weeks. A 2026 review of magnesium and sleep in general concluded the evidence does not support it as a routine insomnia treatment.
Anxiety and mood. We found no published trial of magnesium L-threonate in people with an anxiety disorder. Where anxiety was measured as a secondary outcome, in the 2016 trial, the independent 2023 trial and the company's ADHD trial, there was no meaningful difference from placebo. A positive stress and anxiety report from a small trial appeared in a journal not indexed in PubMed, and we could not verify its numbers.
If sleep is the goal, our guide to magnesium for sleep and anxiety covers the forms and the research.
Label math and cost
Magnesium L-threonate is mostly threonate. EU specifications put magnesium at 7.2 to 8.3 percent of the ingredient, and labels typically list 2,000 mg of Magtein as 144 mg of magnesium. By our arithmetic from the EU specification, about 1.6 to 1.8 g of each 2 g dose is threonate, which is why products take three or four capsules a day.
| Product type | Magnesium per daily serving | Typical cost per day | What it means |
|---|---|---|---|
| Magnesium L-threonate (2 g, usually 3 capsules) | About 144 mg | About $1.00 to $2.30, from Amazon prices on October 28, 2026 | About 40% of the 350 mg supplement limit |
| Magnesium glycinate (about 200 mg) | 200 mg | About $0.13 to $0.50, from our glycinate ranking's listed prices | See our fully reacted glycinate ranking |
| Blends with "Magtein" on the front | Varies | Varies | Some contain 1,000 mg or less of Magtein, half the studied dose, or mix it with other magnesium forms; check the amount |
Costs are our arithmetic from listed prices and change often. Product amounts come from Supplement Facts panels. This table compares magnesium content and price, not effectiveness, and doses above 350 mg of supplemental magnesium a day should be clinician-directed. Ask a clinician first if you have kidney disease, take prescription medicines, or are pregnant or breastfeeding.
Read the claims on the bottle with the research in mind. Several listings we read call it the only magnesium that crosses the blood-brain barrier, which the animal research does not support, while at least one brand more accurately says it did so in preclinical studies. The cognition trials used 1.5 to 2 g of magnesium L-threonate a day, and some products contain less; any amount counts toward your daily magnesium total. For other forms, see our overall magnesium ranking and guide to which magnesium for which goal.
Safety and who should be careful
- Memory problems need a medical check. New, worsening or worrying memory or thinking changes have many causes, some treatable, and need an evaluation. This supplement is not a treatment for dementia, ADHD or any other condition.
- The 350 mg limit. The adult upper limit for magnesium from all supplements combined is 350 mg a day. A 2 g dose supplies about 144 mg, so count any other magnesium you take.
- Kidney disease. Impaired kidney function raises the risk of magnesium building up; ask your doctor first.
- Medicines. Take magnesium at least 2 hours apart from bisphosphonates, and take tetracycline or quinolone antibiotics at least 2 hours before or 4 to 6 hours after it.
- Pregnancy and breastfeeding. The EU authorization excludes pregnant and breastfeeding women, and some labels say it is not recommended for them or for children.
Side effects. In the 2016 trial, all side effects were mild; four in the treated group were judged possibly or probably related (loose stools, dry mouth, stomach upset and high blood pressure), compared with nine in the placebo group. Some labels warn that it may cause sleepiness, drowsiness or headaches. Some listings say it has no laxative effect, but loose stools were among the effects reported in the 2016 trial. EFSA's safety review relied mainly on animal studies of threonate and found no genotoxicity concern; human safety data are limited to short trials.
Frequently asked questions
Does magnesium L-threonate improve memory?
The evidence is limited and mostly sponsored. Two company-funded trials, of 44 and 100 adults, found gains on combined cognitive scores, large in the smaller trial and small in the larger one, where the placebo group improved too. The one independent trial we found that measured cognition, in 109 women, showed no significant difference, though it used a lower dose and a simple screening test. It has not been shown to treat memory loss, and new or worsening memory problems need a medical evaluation.
Is magnesium L-threonate the only magnesium that crosses the blood-brain barrier?
No. All magnesium enters the brain through regulated transport. Magnesium L-threonate raised brain or spinal fluid magnesium in rats and mice, but other forms such as acetyl taurate and citrate also raised brain magnesium in rat or mouse studies, and acetyl taurate did better in a 2026 rat comparison. We found no human study that measured brain magnesium after taking magnesium L-threonate.
Did magnesium L-threonate really reverse brain age by 9 years?
No such thing was measured. The 9.4-year figure came from matching the improvement on one timed test to age norms, calculated after the fact in 44 people, in a trial that, as the paper discloses, was funded, analyzed and written up by the ingredient's developer. It describes test performance, not the biological age of the brain.
Does magnesium L-threonate help with sleep?
The results are mixed. In an 80-person trial, the insomnia severity questionnaire did not differ from placebo, though some sleep-tracking ring scores and a waking questionnaire favored it. In a 100-person trial, ring-measured sleep did not differ and only one of three sleep questionnaires improved. Other magnesium forms have also been tested for sleep, with similarly mixed, low-certainty results, and they cost less.
How much magnesium L-threonate is used in studies?
The two cognition trials used 1.5 to 2 g a day of magnesium L-threonate, often split between morning and evening; 2 g supplies about 144 to 145 mg of magnesium. A sleep trial used 1 g and the independent trial used 1.2 g. Count it toward the 350 mg daily upper limit for supplemental magnesium, and ask your doctor first if you have kidney disease.
Is magnesium L-threonate worth the money?
As a magnesium source it is expensive: about $1 to $2.30 a day for 144 mg of magnesium, several times the cost of magnesium glycinate. Whether the possible small effect on test scores is worth it is a personal call; it has not been independently replicated. Any amount counts toward the 350 mg daily limit for supplemental magnesium.
Is magnesium L-threonate safe?
In short trials side effects were mild, including loose stools, dry mouth and stomach upset, and Europe's food safety agency judged it safe for adults at up to about 3,000 mg a day (about 250 mg of magnesium). The EU authorization excludes pregnant and breastfeeding women. People with kidney disease or those taking bisphosphonates or certain antibiotics should check with a clinician.
The bottom line
Magnesium L-threonate rests on a genuine rodent finding: in rats and mice it raised brain magnesium and improved learning. What has not followed is strong human evidence. We found no human study measuring brain magnesium after taking it, other magnesium forms also reach the rodent brain, and the human trials are small, mostly funded by the companies that sell it, with gains on combined cognitive scores, mixed sleep results and no significant difference in the one independent trial we found that measured cognition. The "nine years younger" figure is a post hoc calculation from one test.
So it is an expensive way to get about 144 mg of magnesium, with a possible small effect on test performance that has not been independently replicated. If you choose it, note that the trials mostly used 1 to 2 g a day, count it toward the 350 mg supplement limit, ask a clinician first if you have kidney disease, take medicines or are pregnant, and skip the brain-age promises. If memory or concentration is genuinely changing, see a clinician first, since many causes of memory change can be identified and treated.